Literature DB >> 17916723

PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis.

Phillip T Hawkins1, Len R Stephens.   

Abstract

Class I phosphoinositide 3-kinase (PI3K) signaling pathways regulate several important cellular functions, including cellular growth, division, survival, and movement. Class IB PI3K (also known as PI3Kgamma) links heterotrimeric GTP-binding protein-coupled receptors to these pathways. Activation of class IB PI3K results in the rapid synthesis of phosphatidylinositol-3,4,5-trisphosphate [PtdIns(3,4,5)P3] and its dephosphorylation product PtdIns(3,4)P2 in the plasma membrane. These two lipid messengers bind to pleckstrin homology domain-containing effectors that regulate a complex signaling web downstream of receptor activation. Characteristic features of this pathway are the regulation of protein kinases and the regulation of small guanosine triphosphatases that control cellular movement, adhesion, contraction, and secretion. Most of the ligands that activate class IB PI3K are involved in coordinating the body's response to injury and infection, and recent studies suggest that small molecule inhibitors of this enzyme may represent a novel class of anti-inflammatory therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916723     DOI: 10.1126/science.1145420

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

Review 1.  The genetics of normal platelet reactivity.

Authors:  Thomas J Kunicki; Diane J Nugent
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

2.  Determinants of platelet count in humans.

Authors:  Martina E Daly
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

3.  Phosphoinositide 3-kinase gamma regulates airway smooth muscle contraction by modulating calcium oscillations.

Authors:  Haihong Jiang; Peter W Abel; Myron L Toews; Caishu Deng; Thomas B Casale; Yan Xie; Yaping Tu
Journal:  J Pharmacol Exp Ther       Date:  2010-05-25       Impact factor: 4.030

Review 4.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

5.  Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells.

Authors:  Simon Hohenester; Anna Gates; Ralf Wimmer; Ulrich Beuers; M Sawkat Anwer; Christian Rust; Cynthia R L Webster
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

6.  Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma.

Authors:  Barbara Kurig; Aliaksei Shymanets; Thomas Bohnacker; Carsten Brock; Mohammad Reza Ahmadian; Michael Schaefer; Antje Gohla; Christian Harteneck; Matthias P Wymann; Elisabeth Jeanclos; Bernd Nürnberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

7.  PI3Kgamma protects from myocardial ischemia and reperfusion injury through a kinase-independent pathway.

Authors:  Bernhard J Haubner; G Gregory Neely; Jakob G J Voelkl; Federico Damilano; Keiji Kuba; Yumiko Imai; Vukoslav Komnenovic; Agnes Mayr; Otmar Pachinger; Emilio Hirsch; Josef M Penninger; Bernhard Metzler
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

8.  Identifying the rules of engagement enabling leukocyte rolling, activation, and adhesion.

Authors:  Jonathan Tang; C Anthony Hunt
Journal:  PLoS Comput Biol       Date:  2010-02-19       Impact factor: 4.475

9.  Hepatic gene expression profile in mice perorally infected with Echinococcus multilocularis eggs.

Authors:  Bruno Gottstein; Matthias Wittwer; Marc Schild; Michael Merli; Stephen L Leib; Norbert Müller; Joachim Müller; Rolf Jaggi
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

10.  Proteomics analysis of the nucleolus in adenovirus-infected cells.

Authors:  Yun W Lam; Vanessa C Evans; Kate J Heesom; Angus I Lamond; David A Matthews
Journal:  Mol Cell Proteomics       Date:  2009-10-07       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.